Questa Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Calyxocalyxoinc.comin𝕏Apr 2026 · $40M
Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared.
HealthtechMedical DevicesPleasanton, US
Chris Buchko(Executive Officer)Douglas Hughes(Executive Officer, Director)Jee Shin(Executive Officer, Director)Mark Kidd(Executive Officer)Joe Catanese(Executive Officer, Director)
Board seatRyan Drant· per SEC Form D
Co-investorsAlly Bridge GroupJanus Henderson Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.